Recursion Pharmaceuticals
RXRX
#4393
Rank
NZ$4.21 B
Marketcap
NZ$8.08
Share price
0.43%
Change (1 day)
-34.37%
Change (1 year)

Market capitalization of Recursion Pharmaceuticals (RXRX)

Market cap: NZ$4.21 Billion

As of January 2026 Recursion Pharmaceuticals has a market cap of NZ$4.21 Billion. This makes Recursion Pharmaceuticals the world's 4393th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Recursion Pharmaceuticals from 2021 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$4.21 B10.13%
2025NZ$3.82 B-25.29%
2024NZ$5.11 B52.11%
2023NZ$3.36 B46.22%
2022NZ$2.30 B-45.69%
2021NZ$4.23 B

End of Day market cap according to different sources

On Jan 18th, 2026 the market cap of Recursion Pharmaceuticals was reported to be:

NZ$4.20 Billion
by Nasdaq info icon info icon
NZ$4.21 Billion
by CompaniesMarketCap info icon info icon